| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/07/2010 | WO2010002895A2 Lysosomal phospholipase a2 (lpla2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis |
| 01/07/2010 | WO2010002891A1 Genetic polymorphisms associated with autoinflammatory diseases, methods of detection and uses thereof |
| 01/07/2010 | WO2010002890A2 Methods of promoting weight loss and associated arrays |
| 01/07/2010 | WO2010002883A2 Methods and devices for single-molecule whole genome analysis |
| 01/07/2010 | WO2010002852A2 Bead array reader based-hemagglutination and hemagglutination inhibition assays |
| 01/07/2010 | WO2010002851A1 Silencing and rig-1 activation by dual function oligonucleotides |
| 01/07/2010 | WO2010002552A1 Process for concentrating and processing fluid samples |
| 01/07/2010 | WO2010002356A1 Methods for predicting tumor response to chemotherapy and selection of tumor treatment |
| 01/07/2010 | WO2010002350A1 On-line measuring system of body substances |
| 01/07/2010 | WO2010002254A1 Markers for detection of legionella pneumophila strains |
| 01/07/2010 | WO2010002042A1 Enzyme substrate for labeling of protein |
| 01/07/2010 | WO2010001969A1 Method for amplification of target nucleic acid sequence, method for detection of mutation by using the method, and reagents for use in the methods |
| 01/07/2010 | WO2010001924A1 Method and specimen for detecting sensitivity to isoniazid in tubercle bacillus |
| 01/07/2010 | WO2010001923A1 Method and specimen for detecting sensitivity to isoniazid in tubercle bacillus |
| 01/07/2010 | WO2010001902A1 Oligonucleotide probe, and use thereof |
| 01/07/2010 | WO2010001891A1 Antibody complex, antigen detection method, and method for production of antibody complex |
| 01/07/2010 | WO2010001841A1 Method for aggregation and/or precipitation of microorganism using mdp1 |
| 01/07/2010 | WO2010001600A1 Positive affect marker gene and use thereof |
| 01/07/2010 | WO2010001419A2 Copy number variations predictive of risk of schizophrenia |
| 01/07/2010 | WO2010001358A2 Diagnostic polymorphisms for cardiac disease |
| 01/07/2010 | WO2010001312A1 Separation-free methods of pcr detection using serrs |
| 01/07/2010 | WO2010001263A2 Method for diagnosing and predicting cerebellar ataxia |
| 01/07/2010 | WO2010001254A2 Method and apparatus for sorting cells |
| 01/07/2010 | WO2010001212A2 Probes for use in diagnosing porphyria and allelic quantification of porphyria related genes by ligation and amplification reactions |
| 01/07/2010 | WO2010001162A1 Freeze-dried compositions for biochemical reactions |
| 01/07/2010 | WO2010001074A2 Novel detection probe |
| 01/07/2010 | WO2010000907A1 Genomic fingerprint of mammary cancer |
| 01/07/2010 | WO2010000848A1 In vitro diagnosis/prognosis method and kit for assessment of tolerance in liver transplantation |
| 01/07/2010 | WO2010000796A1 A method for predicting clinical outcome of patients with non-small cell lung carcinoma |
| 01/07/2010 | WO2010000680A1 Method for the detection of specific nucleic acid hybridization |
| 01/07/2010 | WO2010000593A1 Biochips for detecting the enzymatic activity of a protease enzyme |
| 01/07/2010 | WO2010000592A2 Cyclopeptides used as mmp-type protease enzyme inhibitors |
| 01/07/2010 | WO2010000591A2 Fluorescent cyclic peptides, methods for the preparation thereof, and use of said peptides for measuring the enzymatic activity of a protease enzyme |
| 01/07/2010 | WO2010000474A1 Dna methylation analysis of regulatory t cells through dna-methylation analysis of the tsdr region of the gene foxp3 |
| 01/07/2010 | WO2010000427A1 System and method for detection of hiv tropism variants |
| 01/07/2010 | WO2010000320A1 In vitro diagnosis/prognosis method and kit for assessment of tolerance in liver transplantation |
| 01/07/2010 | WO2009140556A3 Genotype and expression analysis for use in predicting outcome and therapy selection |
| 01/07/2010 | WO2009140550A9 Diagnosis of melanoma and solar lentigo by nucleic acid analysis |
| 01/07/2010 | WO2009140541A3 Dual labeling methods for measuring cellular proliferation |
| 01/07/2010 | WO2009140436A3 Guanylyl cyclase c qrt-pcr |
| 01/07/2010 | WO2009140374A3 Inactivatable target capture oligomers for use in the selective hybridization and capture of target nucleic acid sequences |
| 01/07/2010 | WO2009139929A3 Methods and systems for universal carrier screening |
| 01/07/2010 | WO2009138954A3 Gene synthesis by convergent assembly of oligonucleotide subsets |
| 01/07/2010 | WO2009137807A3 Compositions and methods related to mirna modulation of neovascularization or angiogenesis |
| 01/07/2010 | WO2009137257A3 Method and apparatus for analyzing dna |
| 01/07/2010 | WO2009137255A3 Method for evaluating and comparing immunorepertoires |
| 01/07/2010 | WO2009137139A3 Methods of determining antibiotic resistance |
| 01/07/2010 | WO2009132354A3 Method for confirming the presence of an analyte |
| 01/07/2010 | WO2009132257A3 Cytological methods for detecting cancer |
| 01/07/2010 | WO2009132124A3 Geometric patterns and lipid bilayers for dna molecule organization and uses thereof |
| 01/07/2010 | WO2009130176A9 Antiviral therapy |
| 01/07/2010 | WO2009123737A3 Advanced detection of sepsis |
| 01/07/2010 | WO2009120903A3 Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof |
| 01/07/2010 | WO2009120372A3 Compositions and methods for nucleic acid sequencing |
| 01/07/2010 | WO2009117595A3 Sequence variations on chromosome 15 predicting risk for lung cancer |
| 01/07/2010 | WO2009117517A3 Nanopore and carbon nanotube based dna sequencer |
| 01/07/2010 | WO2009117122A3 Genetic analysis |
| 01/07/2010 | WO2009114817A3 Pttg1 as a biomarker for cancer treatment |
| 01/07/2010 | WO2009114185A3 Methods and compositions for translational profiling and molecular phenotyping |
| 01/07/2010 | WO2009111461A3 Microfluidic flow cell |
| 01/07/2010 | WO2009111298A3 Processing of biological growth media based on measured manufacturing characteristics |
| 01/07/2010 | WO2009105590A3 Identification of pediatric onset inflammatory bowel disease loci and methods of use thereof for the diagnosis and treatment of the same |
| 01/07/2010 | WO2009105077A3 Methods for preparing modified biomolecules, modified biomolecules and methods for using same |
| 01/07/2010 | WO2009102844A3 Methods and compositions for identifying cells by combinatorial fluoresence imaging |
| 01/07/2010 | WO2009102349A3 Sensors for measuring contaminants |
| 01/07/2010 | WO2009097511A3 Two stage enrichment of cell-free fetal dna in maternal plasma |
| 01/07/2010 | WO2009097397A3 Metalloproteinase binding proteins |
| 01/07/2010 | WO2009097339A9 Methods of monitoring metabolic pathways |
| 01/07/2010 | WO2009092005A3 Methods of generating cardiomyocytes and cardiac progenitors and compositions |
| 01/07/2010 | WO2009089548A3 Malignancy-risk signature from histologically normal breast tissue |
| 01/07/2010 | WO2009076292A3 Rationally-designed meganucleases with recognition sequences found in dnase hypersensitive regions of the human genome |
| 01/07/2010 | WO2009073252A3 Methods and compositions for determining cholesterol-reducing properties of compounds |
| 01/07/2010 | WO2009059321A3 Rca locus analysis to assess susceptibility to amd and mpgnii |
| 01/07/2010 | WO2009023125A9 Neuronostatin and its uses |
| 01/07/2010 | WO2008102340A3 Kits and methods for determining colon cleanliness |
| 01/07/2010 | WO2008089236A3 Compositions and methods for diagnosing, treating, and preventing prostate conditions |
| 01/07/2010 | WO2008087647A3 Methods of diagnosing, monitoring treatment and treating systemic lupus erythematosus (sle) |
| 01/07/2010 | US20100005546 Compositions and methods for the improvement of plants |
| 01/07/2010 | US20100005538 Lettuce line p2231-3013596 |
| 01/07/2010 | US20100004436 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/07/2010 | US20100004435 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/07/2010 | US20100004434 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/07/2010 | US20100004324 Antimicrobial compounds and methods of use thereof |
| 01/07/2010 | US20100004322 TCL1 Expression in Chronic Lymphocytic Leukemia (CLL) Regulated by MIR-29 and MIR-181 |
| 01/07/2010 | US20100004318 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/07/2010 | US20100004317 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/07/2010 | US20100004253 Biomarkers of target modulation, efficacy, diagnosis and/or prognosis for raf inhibitors |
| 01/07/2010 | US20100004213 Gene expression markers for inflammatory bowel disease |
| 01/07/2010 | US20100004210 Method and substances for treating t-cell mediated autoimmune diseases |
| 01/07/2010 | US20100004196 Heparan sulfate proteoglycan composition and use thereof |
| 01/07/2010 | US20100004195 Decoy Influenza Therapies |
| 01/07/2010 | US20100004171 Therapeutic Methods for Neuropathic Pain |
| 01/07/2010 | US20100004168 Use of Crystallin For The Modulation of Angiogenesis |
| 01/07/2010 | US20100004164 Platelet aggregation inhibitor composition |
| 01/07/2010 | US20100004162 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses thereof |
| 01/07/2010 | US20100004161 Toll Like Receptor 4 Dysfunction and the Biological Applications Thereof |
| 01/07/2010 | US20100004142 siRNA targeting myeloid cell Leukemia sequence 1 |
| 01/07/2010 | US20100004140 Method of prognosis |
| 01/07/2010 | US20100004138 Reagent for detecting biopolymer and method for detecting biopolymer |
| 01/07/2010 | US20100004137 Characterization of biochips containing self-assembled monolayers |